v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2026
Mar. 31, 2026
Current assets:    
Cash and cash equivalents $ 307,833 $ 209,024
Short-term investments 0 59,865
Research and development incentives receivable 0 1,619
Inventory, net 9,867 0
Prepaid expenses and other current assets 6,335 8,611
Total current assets 324,035 279,119
Property, plant and equipment, net 10,703 12,974
Restricted cash 1,703 1,703
Other non-current assets 3,474 2,942
Right-of-use asset - operating leases 2,860 3,270
Right-of-use asset - finance leases 31,165 32,380
Total assets 373,940 332,388
Current liabilities:    
Accounts payable 5,959 6,671
Accrued expenses and other current liabilities 35,556 47,516
Operating lease liabilities, current 1,112 1,158
Finance lease liabilities, current 2,926 2,883
Total current liabilities 45,553 58,228
Operating lease liabilities, non-current 1,938 2,328
Finance lease liabilities, non-current 21,450 21,909
Long term debt, net of discount 99,766 83,308
Other liabilities, non-current 455 455
Total liabilities 169,162 166,228
Commitments and contingencies (Note 15)
Stockholders' equity    
Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2026 and 150,000,000 as of March 31, 2026; 94,805,154 and 82,716,923 shares issued and outstanding as of September 30, 2026 and March 31, 2026, respectively 95 82
Additional paid-in capital 1,588,167 1,423,194
Accumulated deficit (1,389,406) (1,262,519)
Accumulated other comprehensive income 5,922 5,403
Total stockholders' equity 204,778 166,160
Total liabilities and stockholders' equity $ 373,940 $ 332,388